M. R. Kale, M. S. Baig, and A. Lamb, “A prospective observational pharmacovigilance study of adverse drug reaction monitoring in patients of tuberculosis receiving category I and II treatment regimens at tertiary care hospital”, Int J Basic Clin Pharmacol, vol. 8, no. 5, pp. 875–880, Apr. 2019.